BioLineRx (BLRX) FCF Margin (2018 - 2026)
BioLineRx's FCF Margin came in at -1094.22% for the quarter ended Jun 30, 2026, down 1035.99 percentage points from -58.22% a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) FCF Margin (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioLineRx reported FCF Margin of -885.73%, down 762.78 percentage points year-over-year; for the year ended Dec 31, 2025, it was -682.12%, down 530.70 percentage points from the prior year.
- Going back by year, FCF Margin was -151.42% in the year ended Dec 31, 2024 (+317.17 pp) and -468.58% in the year ended Dec 31, 2023.
- The five-year range for quarterly FCF Margin is -1649.48% (the quarter ended Dec 31, 2025) to -58.22% (the quarter ended Jun 30, 2025).
- Year-over-year, FCF Margin increased in 1 of the last five quarters, with an average year-over-year change of -713.19 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.06 Bn | 1,102.65 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 367.24 Bn | 321.62 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.48 Bn | 235.17 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 2.01% |
| 10 | BioLineRx | 8.67 Mn | -67.85 Mn | 235,000.00 | -1,094.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,094.22% |
| Dec 31, 2025 | -1,649.48% |
| Sep 30, 2025 | -493.21% |
| Jun 30, 2025 | -58.22% |
| Mar 31, 2025 | -1,016.08% |
| Dec 31, 2024 | -74.24% |
| Sep 30, 2024 | -196.38% |
| Jun 30, 2024 | -211.76% |
| Mar 31, 2024 | -205.35% |
| Sep 30, 2021 | -1,496.97% |
| Mar 31, 2021 | -1,584.18% |
| Sep 30, 2020 | -859.91% |
| Mar 31, 2020 | -1,471.18% |
| Sep 30, 2019 | -741.98% |
| Mar 31, 2019 | -763.89% |
| Sep 30, 2018 | -53,263.64% |
API Access
BioLineRx FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();